Nurix Therapeutics, Inc. (NRIX) is making waves in the biotechnology sector, with promising developments in its clinical-stage pipeline and strong analyst support suggesting a notable upside..
Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology company, is making waves in the healthcare sector with its ambitious focus on innovative treatments for inflammatory bowel disease..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is gaining attention in the biotechnology sector, not only for its focus on developing gene therapies for rare diseases but also..
For investors seeking exposure to the dynamic world of biotechnology, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) presents a compelling opportunity. With a market capitalization of $1.19..
Nuvation Bio Inc. (NASDAQ: NUVB) has recently captured the attention of investors, thanks to its impressive revenue growth and a significant potential upside. With a market..
Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of investors with its promising potential upside, estimated at an impressive 90.58%, according to recent analyst ratings...
Investors scouting for opportunities in the healthcare sector may want to take a closer look at Collegium Pharmaceutical, Inc. (NASDAQ: COLL). With a market capitalization of..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a New York-based biotechnology company, has captured the attention of investors with its promising therapeutic developments in the oncology sector. With..
Investors are turning their spotlight on Geron Corporation (NASDAQ: GERN), a commercial-stage biopharmaceutical company that promises a substantial upside potential of 180.11%, according to recent analyst..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands at the crossroads of innovation and tradition in the healthcare sector. With a market capitalization of $1.75 billion, this..
